These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30028196)

  • 41. Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.
    Francis C; Courbon G; Gerber C; Neuburg S; Wang X; Dussold C; Capella M; Qi L; Isakova T; Mehta R; Martin A; Wolf M; David V
    Kidney Int; 2019 Dec; 96(6):1346-1358. PubMed ID: 31668632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microvascular disease in chronic kidney disease: the base of the iceberg in cardiovascular comorbidity.
    Querfeld U; Mak RH; Pries AR
    Clin Sci (Lond); 2020 Jun; 134(12):1333-1356. PubMed ID: 32542397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of phosphate on vascular function under normal conditions and influence of the uraemic state.
    Six I; Maizel J; Barreto FC; Rangrez AY; Dupont S; Slama M; Tribouilloy C; Choukroun G; Mazière JC; Bode-Boeger S; Kielstein JT; Drüeke TB; Massy ZA
    Cardiovasc Res; 2012 Oct; 96(1):130-9. PubMed ID: 22822101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Short-term treatment with a beta-blocker with vasodilative capacities improves intrarenal endothelial function in experimental renal failure.
    Gschwend S; Haug MB; Nierhaus M; Schulz A; Vetter R; Kossmehl P; Orzechowski HD; Scholze J; Rothermund L; Kreutz R
    Life Sci; 2009 Sep; 85(11-12):431-7. PubMed ID: 19635487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.
    Bech AP; Bouma-de Krijger A; van Zuilen AD; Bots ML; van den Brand JA; Blankestijn PJ; Wetzels JF; Vervloet MG
    J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
    Williams MJ; Sugatani T; Agapova OA; Fang Y; Gaut JP; Faugere MC; Malluche HH; Hruska KA
    Kidney Int; 2018 Jan; 93(1):147-158. PubMed ID: 28843411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired NO-mediated vasodilation with increased superoxide but robust EDHF function in right ventricular arterial microvessels of pulmonary hypertensive rats.
    Kajiya M; Hirota M; Inai Y; Kiyooka T; Morimoto T; Iwasaki T; Endo K; Mohri S; Shimizu J; Yada T; Ogasawara Y; Naruse K; Ohe T; Kajiya F
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2737-44. PubMed ID: 17220192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coronary microvascular dysfunction after long-term diabetes and hypercholesterolemia.
    Sorop O; van den Heuvel M; van Ditzhuijzen NS; de Beer VJ; Heinonen I; van Duin RW; Zhou Z; Koopmans SJ; Merkus D; van der Giessen WJ; Danser AH; Duncker DJ
    Am J Physiol Heart Circ Physiol; 2016 Dec; 311(6):H1339-H1351. PubMed ID: 27591223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Cai X; Lee J; Scialla JJ; Bansal N; Sondheimer JH; Chen J; Hamm LL; Ricardo AC; Navaneethan SD; Deo R; Rahman M; Feldman HI; Go AS; Isakova T; Wolf M;
    JAMA Cardiol; 2016 Aug; 1(5):548-56. PubMed ID: 27434583
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-mediated vascular intercellular communication is altered in chronic kidney disease.
    Zietzer A; Steffen E; Niepmann S; Düsing P; Hosen MR; Liu W; Jamme P; Al-Kassou B; Goody PR; Zimmer S; Reiners KS; Pfeifer A; Böhm M; Werner N; Nickenig G; Jansen F
    Cardiovasc Res; 2022 Jan; 118(1):316-333. PubMed ID: 33135066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibroblast Growth Factor-23-A Potential Uremic Toxin.
    Kuczera P; Adamczak M; Wiecek A
    Toxins (Basel); 2016 Dec; 8(12):. PubMed ID: 27941640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibroblast growth factor 23 actions in inflammation: a key factor in CKD outcomes.
    Rossaint J; Unruh M; Zarbock A
    Nephrol Dial Transplant; 2017 Sep; 32(9):1448-1453. PubMed ID: 27659127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis.
    Böckmann I; Lischka J; Richter B; Deppe J; Rahn A; Fischer DC; Heineke J; Haffner D; Leifheit-Nestler M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
    Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
    Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
    Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway.
    Stevens KK; Denby L; Patel RK; Mark PB; Kettlewell S; Smith GL; Clancy MJ; Delles C; Jardine AG
    Nephrol Dial Transplant; 2017 Oct; 32(10):1617-1627. PubMed ID: 27448672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N
    PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function.
    Vergara N; de Mier MVP; Rodelo-Haad C; Revilla-González G; Membrives C; Díaz-Tocados JM; Martínez-Moreno JM; Torralbo AI; Herencia C; Rodríguez-Ortiz ME; López-Baltanás R; Richards WG; Felsenfeld A; Almadén Y; Martin-Malo A; Ureña J; Santamaría R; Soriano S; Rodríguez M; Muñoz-Castañeda JR
    Nephrol Dial Transplant; 2023 Feb; 38(2):322-343. PubMed ID: 35867864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model.
    Dai B; David V; Martin A; Huang J; Li H; Jiao Y; Gu W; Quarles LD
    PLoS One; 2012; 7(9):e44161. PubMed ID: 22970174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.